PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 74 filers reported holding PMV PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,660,416 | -1.9% | 270,426 | 0.0% | 0.02% | +5.3% |
| Q2 2023 | $1,692,867 | -60.5% | 270,426 | -69.9% | 0.02% | -61.2% |
| Q1 2023 | $4,290,906 | -48.9% | 899,561 | -6.8% | 0.05% | -51.0% |
| Q4 2022 | $8,395,370 | -19.8% | 964,985 | +9.7% | 0.10% | -21.9% |
| Q3 2022 | $10,466,000 | -11.7% | 879,462 | +5.8% | 0.13% | -5.9% |
| Q2 2022 | $11,848,000 | +0.1% | 831,466 | +46.3% | 0.14% | +30.8% |
| Q1 2022 | $11,833,000 | -5.7% | 568,349 | +4.6% | 0.10% | +3.0% |
| Q4 2021 | $12,550,000 | -20.2% | 543,305 | +3.0% | 0.10% | -17.9% |
| Q3 2021 | $15,717,000 | +6.2% | 527,420 | +21.8% | 0.12% | +10.8% |
| Q2 2021 | $14,796,000 | +13.9% | 433,128 | +9.6% | 0.11% | +14.4% |
| Q1 2021 | $12,994,000 | -46.2% | 395,063 | +0.6% | 0.10% | -48.1% |
| Q4 2020 | $24,149,000 | +70.1% | 392,608 | -1.8% | 0.19% | +38.5% |
| Q3 2020 | $14,200,000 | – | 400,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $23,012,000 | 42.78% |
| Euclidean Capital LLC | 2,336,909 | $33,301,000 | 28.32% |
| OUP Management Co., LLC | 989,232 | $14,097,000 | 19.40% |
| Nextech Invest Ltd. | 1,385,807 | $19,748,000 | 6.66% |
| Boxer Capital, LLC | 3,498,636 | $49,856,000 | 3.16% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $7,842,000 | 1.84% |
| Orbimed Advisors | 6,563,077 | $93,524,000 | 1.70% |
| RTW INVESTMENTS, LP | 4,395,677 | $62,638,000 | 1.62% |
| ACUTA CAPITAL PARTNERS, LLC | 152,500 | $2,173,000 | 1.21% |
| Avoro Capital Advisors LLC | 3,100,000 | $44,175,000 | 0.87% |